C83.3 Category · further specificity required Diffuse large B-cell lymphoma
ICD-10-CM C83.3 identifies “Diffuse large B-cell lymphoma” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Inclusion terms7
- Anaplastic diffuse large B-cell lymphoma
- CD30-positive diffuse large B-cell lymphoma
- Centroblastic diffuse large B-cell lymphoma
- Diffuse large B-cell lymphoma, subtype not specified
- Immunoblastic diffuse large B-cell lymphoma
- Plasmablastic diffuse large B-cell lymphoma
- T-cell rich diffuse large B-cell lymphoma
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C83 · Non-follicular lymphoma
Excludes 11
personal history of non-Hodgkin lymphoma (Z85.72)
More specific codes
C83.30Diffuse large B-cell lymphoma, unspecified siteBillable / specificC83.31Diffuse large B-cell lymphoma, lymph nodes of head, face, and neckBillable / specificC83.32Diffuse large B-cell lymphoma, intrathoracic lymph nodesBillable / specificC83.33Diffuse large B-cell lymphoma, intra-abdominal lymph nodesBillable / specificC83.34Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limbBillable / specificC83.35Diffuse large B-cell lymphoma, lymph nodes of inguinal region and lower limbBillable / specificC83.36Diffuse large B-cell lymphoma, intrapelvic lymph nodesBillable / specificC83.37Diffuse large B-cell lymphoma, spleenBillable / specificC83.38Diffuse large B-cell lymphoma, lymph nodes of multiple sitesBillable / specificC83.39Diffuse large B-cell lymphoma, extranodal and solid organ sitesCategory · further specificity requiredC83.3ADiffuse large B-cell lymphoma, in remissionBillable / specificOfficial index references
Official index references (9)
Lymphoma(of) (malignant) (9)
- Lymphoma(of) (malignant) › diffuse large cellDisease index
- Lymphoma(of) (malignant) › diffuse large cell › anaplasticDisease index
- Lymphoma(of) (malignant) › diffuse large cell › B-cellDisease index
- Lymphoma(of) (malignant) › diffuse large cell › CD30-positiveDisease index
- Lymphoma(of) (malignant) › diffuse large cell › centroblasticDisease index
- Lymphoma(of) (malignant) › diffuse large cell › immunoblasticDisease index
- Lymphoma(of) (malignant) › diffuse large cell › plasmablasticDisease index
- Lymphoma(of) (malignant) › diffuse large cell › subtype not specifiedDisease index
- Lymphoma(of) (malignant) › diffuse large cell › T-cell richDisease index
References from other codes (2)
Excludes 1 · T-cell rich B-cell lymphoma (C83.3-)
Excludes 1 · high malignant (diffuse large B-cell) lymphoma (C83.3-)
History
Code history
Latest recorded change · FY2025
ChangedUnchanged
FY2025
Effective from
- Code-level rules changed
Diffuse large B-cell lymphoma
Category — select a more specific code
CDC/NCHS · FY2025All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | Code-level rules changed |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.